RLN3
Basic information
Region (hg38): 19:14028148-14031551
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RLN3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 11 | |||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 10 | 3 | 0 |
Variants in RLN3
This is a list of pathogenic ClinVar variants found in the RLN3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-14028236-C-T | not specified | Uncertain significance (Dec 26, 2023) | ||
19-14028266-C-T | not specified | Likely benign (Dec 21, 2023) | ||
19-14028292-T-C | Likely benign (Feb 13, 2018) | |||
19-14028325-C-T | Likely benign (Jun 08, 2018) | |||
19-14028370-G-C | not specified | Uncertain significance (Mar 11, 2022) | ||
19-14028383-A-G | not specified | Uncertain significance (Aug 21, 2023) | ||
19-14028385-G-A | not specified | Uncertain significance (Jan 10, 2022) | ||
19-14030743-A-G | not specified | Uncertain significance (Mar 01, 2023) | ||
19-14030755-G-A | not specified | Uncertain significance (Oct 06, 2021) | ||
19-14030764-A-G | not specified | Uncertain significance (Mar 01, 2024) | ||
19-14030806-C-A | Uncertain significance (Jan 01, 2019) | |||
19-14030874-G-C | not specified | Uncertain significance (Jan 18, 2023) | ||
19-14030881-T-C | not specified | Uncertain significance (Nov 28, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RLN3 | protein_coding | protein_coding | ENST00000431365 | 2 | 2895 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0134 | 0.682 | 125553 | 0 | 83 | 125636 | 0.000330 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.160 | 95 | 90.7 | 1.05 | 0.00000559 | 897 |
Missense in Polyphen | 26 | 28.752 | 0.90427 | 306 | ||
Synonymous | 1.24 | 30 | 40.0 | 0.751 | 0.00000259 | 310 |
Loss of Function | 0.569 | 3 | 4.27 | 0.703 | 3.67e-7 | 29 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00419 | 0.00419 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000881 | 0.0000880 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000658 | 0.0000653 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in neuropeptide signaling processes. Ligand for LGR7, relaxin-3 receptor-1 (GPCR135) and relaxin-3 receptor-2 (GPCR142).;
- Pathway
- Relaxin signaling pathway - Homo sapiens (human);Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;Relaxin receptors;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (i) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.111
Intolerance Scores
- loftool
- 0.548
- rvis_EVS
- 0.57
- rvis_percentile_EVS
- 81.99
Haploinsufficiency Scores
- pHI
- 0.142
- hipred
- N
- hipred_score
- 0.208
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.564
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rln3
- Phenotype
- growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); pigmentation phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;regulation of signaling receptor activity
- Cellular component
- extracellular region
- Molecular function
- G protein-coupled receptor binding;hormone activity;protein binding